Related Experiment Video
Updated: Mar 31, 2026
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism
Peter Ranger1, Bart A Ellenbroek2
1School of Psychology, Victoria University of Wellington, PO Box 600, Wellington, New Zealand.
Insights
Valproic acid (VPA) is an anticonvulsant linked to birth defects, including autism spectrum disorder (ASD). This review examines the VPA animal model for ASD and its molecular causes.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Valproic acid (VPA) is a widely used anticonvulsant and mood stabilizer.
- While effective in adults, VPA exhibits teratogenic properties, causing congenital malformations.
- Prenatal VPA exposure is associated with neurodevelopmental changes resembling autism spectrum disorder (ASD).
Purpose of the Study:
- To explore the relationship between prenatal Valproic acid exposure and autism spectrum disorder.
- To evaluate the utility of the VPA-induced animal model in ASD research.
- To elucidate the molecular mechanisms underlying VPA's teratogenic effects.
Main Methods:
- Review of existing human and animal studies on VPA exposure and developmental outcomes.
- Analysis of the VPA animal model for its relevance to ASD.
- Discussion of molecular pathways implicated in VPA teratogenicity.
Main Results:
- Convincing evidence links prenatal VPA exposure to neurodevelopmental abnormalities.
- The VPA animal model demonstrates features relevant to ASD.
- Specific molecular mechanisms contributing to VPA's teratogenic effects are being identified.
Conclusions:
- Prenatal Valproic acid exposure is a significant risk factor for autism spectrum disorder.
- The VPA animal model serves as a valuable tool for investigating ASD.
- Understanding molecular mechanisms can inform preventative strategies for VPA-induced developmental disorders.
Abstract:
Valproic acid or valproate (VPA) is an anti-convulsant and mood stabiliser effective in treating epilepsy and bipolar disorders. Although in adults VPA is well tolerated and safe, there is convincing evidence that it has teratogenic properties, ranging from mild neurodevelopmental changes to severe congenital malformations. In particular, studies involving humans and other animals have shown that prenatal exposure to VPA can induce developmental abnormalities reminiscent of autism spectrum disorder (ASD). In this chapter, we discuss the connection between VPA and ASD, evaluate the VPA animal model of ASD, and describe the possible molecular mechanisms underlying VPA's teratogenic properties.
